

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | superoxide anion generation (GO:0042554) | 6.02277637 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.87432475 |
| 3 | negative T cell selection (GO:0043383) | 5.86733250 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.66400658 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.66400658 |
| 6 | negative thymic T cell selection (GO:0045060) | 5.65084582 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.62571162 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.60670626 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 5.43534926 |
| 10 | positive thymic T cell selection (GO:0045059) | 5.27058033 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.22730580 |
| 12 | positive T cell selection (GO:0043368) | 5.05596747 |
| 13 | response to interleukin-15 (GO:0070672) | 4.96614039 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 4.93584294 |
| 15 | positive regulation of B cell differentiation (GO:0045579) | 4.87244492 |
| 16 | regulation of B cell differentiation (GO:0045577) | 4.70242934 |
| 17 | thymic T cell selection (GO:0045061) | 4.61268153 |
| 18 | T cell selection (GO:0045058) | 4.52816804 |
| 19 | positive regulation of granulocyte differentiation (GO:0030854) | 4.26633376 |
| 20 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.24801512 |
| 21 | activated T cell proliferation (GO:0050798) | 4.20271057 |
| 22 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.99691828 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.93486230 |
| 24 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.92188347 |
| 25 | regulation of regulatory T cell differentiation (GO:0045589) | 3.89794373 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.80815626 |
| 27 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.76032876 |
| 28 | G-protein coupled receptor internalization (GO:0002031) | 3.74697343 |
| 29 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.73550607 |
| 30 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.71673651 |
| 31 | T cell receptor signaling pathway (GO:0050852) | 3.69953031 |
| 32 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.59277554 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.58418652 |
| 34 | tolerance induction (GO:0002507) | 3.57024602 |
| 35 | mast cell activation (GO:0045576) | 3.53275352 |
| 36 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.49332694 |
| 37 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.49332694 |
| 38 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.48713727 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45912564 |
| 40 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.43971953 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.43904974 |
| 42 | response to host immune response (GO:0052572) | 3.42238555 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42238555 |
| 44 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.39220400 |
| 45 | detection of other organism (GO:0098543) | 3.38088309 |
| 46 | cytidine metabolic process (GO:0046087) | 3.38073763 |
| 47 | cytidine catabolic process (GO:0006216) | 3.38073763 |
| 48 | cytidine deamination (GO:0009972) | 3.38073763 |
| 49 | T cell costimulation (GO:0031295) | 3.37587144 |
| 50 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.35984900 |
| 51 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.33849686 |
| 52 | modulation by symbiont of host immune response (GO:0052553) | 3.33779796 |
| 53 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33779796 |
| 54 | modulation by symbiont of host defense response (GO:0052031) | 3.33779796 |
| 55 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33779796 |
| 56 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33779796 |
| 57 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33779796 |
| 58 | superoxide metabolic process (GO:0006801) | 3.32817156 |
| 59 | lymphocyte costimulation (GO:0031294) | 3.32743348 |
| 60 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.29838054 |
| 61 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.23653191 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 3.23396947 |
| 63 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.23045294 |
| 64 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.23045294 |
| 65 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.20515028 |
| 66 | detection of bacterium (GO:0016045) | 3.20226531 |
| 67 | response to type I interferon (GO:0034340) | 3.19170402 |
| 68 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.17646178 |
| 69 | regulation of alpha-beta T cell activation (GO:0046634) | 3.15089643 |
| 70 | regulation of cell killing (GO:0031341) | 3.14984045 |
| 71 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.13993533 |
| 72 | regulation of T cell tolerance induction (GO:0002664) | 3.13662562 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.13310480 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.13310480 |
| 75 | positive regulation of cell killing (GO:0031343) | 3.11995426 |
| 76 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.10930307 |
| 77 | dendritic cell migration (GO:0036336) | 3.10029957 |
| 78 | dendritic cell chemotaxis (GO:0002407) | 3.08784435 |
| 79 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.07355508 |
| 80 | neutrophil activation (GO:0042119) | 3.05606173 |
| 81 | interferon-gamma production (GO:0032609) | 3.05475985 |
| 82 | positive regulation of antigen processing and presentation (GO:0002579) | 3.05294237 |
| 83 | regulation of granulocyte differentiation (GO:0030852) | 3.03794906 |
| 84 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.03167031 |
| 85 | Peyers patch development (GO:0048541) | 3.03167031 |
| 86 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.02522133 |
| 87 | regulation of activation of Janus kinase activity (GO:0010533) | 3.02499956 |
| 88 | T cell homeostasis (GO:0043029) | 3.00299060 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00104657 |
| 90 | response to host (GO:0075136) | 2.99413065 |
| 91 | response to host defenses (GO:0052200) | 2.99413065 |
| 92 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99413065 |
| 93 | DNA deamination (GO:0045006) | 2.99323355 |
| 94 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.99142482 |
| 95 | negative regulation of mast cell activation (GO:0033004) | 2.98529787 |
| 96 | mature B cell differentiation (GO:0002335) | 2.98105172 |
| 97 | germinal center formation (GO:0002467) | 2.96982284 |
| 98 | energy homeostasis (GO:0097009) | 2.96906866 |
| 99 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.96789286 |
| 100 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.96641351 |
| 101 | polyketide metabolic process (GO:0030638) | 2.96179533 |
| 102 | doxorubicin metabolic process (GO:0044598) | 2.96179533 |
| 103 | daunorubicin metabolic process (GO:0044597) | 2.96179533 |
| 104 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.96015061 |
| 105 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.95913114 |
| 106 | centriole assembly (GO:0098534) | 2.95348159 |
| 107 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.95004434 |
| 108 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.94429997 |
| 109 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.94086983 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93222231 |
| 111 | regulation of memory T cell differentiation (GO:0043380) | 2.93051968 |
| 112 | positive regulation of interleukin-2 production (GO:0032743) | 2.91784601 |
| 113 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.90580649 |
| 114 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.89283624 |
| 115 | positive regulation of T cell mediated immunity (GO:0002711) | 2.88602067 |
| 116 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.88449272 |
| 117 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.88449272 |
| 118 | cellular response to interleukin-15 (GO:0071350) | 2.87506943 |
| 119 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.85805819 |
| 120 | actin nucleation (GO:0045010) | 2.85210230 |
| 121 | regulation of T cell mediated immunity (GO:0002709) | 2.84956478 |
| 122 | alpha-beta T cell differentiation (GO:0046632) | 2.84789450 |
| 123 | positive regulation of isotype switching (GO:0045830) | 2.84650943 |
| 124 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.83048650 |
| 125 | detection of molecule of bacterial origin (GO:0032490) | 2.82673908 |
| 126 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.82405375 |
| 127 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.79601101 |
| 128 | response to peptidoglycan (GO:0032494) | 2.77144157 |
| 129 | granulocyte activation (GO:0036230) | 2.75737120 |
| 130 | negative regulation of granulocyte differentiation (GO:0030853) | 2.75341691 |
| 131 | meiotic chromosome segregation (GO:0045132) | 2.74442575 |
| 132 | regulation of antigen processing and presentation (GO:0002577) | 2.69541861 |
| 133 | B cell proliferation (GO:0042100) | 2.69311015 |
| 134 | microglial cell activation (GO:0001774) | 2.64483834 |
| 135 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.63263096 |
| 136 | cellular extravasation (GO:0045123) | 2.63228125 |
| 137 | regulation of germinal center formation (GO:0002634) | 2.63100224 |
| 138 | T cell migration (GO:0072678) | 2.59184925 |
| 139 | response to muramyl dipeptide (GO:0032495) | 2.58891132 |
| 140 | neutrophil activation involved in immune response (GO:0002283) | 2.58226103 |
| 141 | cellular response to exogenous dsRNA (GO:0071360) | 2.56921313 |
| 142 | detection of external biotic stimulus (GO:0098581) | 2.54892542 |
| 143 | DNA integration (GO:0015074) | 2.52601853 |
| 144 | mature B cell differentiation involved in immune response (GO:0002313) | 2.52265164 |
| 145 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.51992056 |
| 146 | B cell homeostasis (GO:0001782) | 2.50783475 |
| 147 | histamine secretion (GO:0001821) | 2.47086818 |
| 148 | positive regulation of heat generation (GO:0031652) | 2.47068550 |
| 149 | regulation of RIG-I signaling pathway (GO:0039535) | 2.46474968 |
| 150 | negative regulation of viral genome replication (GO:0045071) | 2.45670600 |
| 151 | regulation of platelet aggregation (GO:0090330) | 2.45459398 |
| 152 | myeloid dendritic cell activation (GO:0001773) | 2.45345539 |
| 153 | histone H3-K36 demethylation (GO:0070544) | 2.44653386 |
| 154 | regulation of interleukin-8 secretion (GO:2000482) | 2.43452378 |
| 155 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.43059236 |
| 156 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.42847782 |
| 157 | kinetochore assembly (GO:0051382) | 2.42387241 |
| 158 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.42156930 |
| 159 | lymph node development (GO:0048535) | 2.41495883 |
| 160 | cellular response to interferon-beta (GO:0035458) | 2.40275862 |
| 161 | regulation of DNA endoreduplication (GO:0032875) | 2.39562656 |
| 162 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.36389343 |
| 163 | leukocyte aggregation (GO:0070486) | 2.34964014 |
| 164 | detection of biotic stimulus (GO:0009595) | 2.33590195 |
| 165 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.32658702 |
| 166 | positive regulation of interferon-alpha production (GO:0032727) | 2.32319233 |
| 167 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.31588646 |
| 168 | T-helper cell differentiation (GO:0042093) | 2.31588646 |
| 169 | regulation of interleukin-1 secretion (GO:0050704) | 2.31572304 |
| 170 | ganglion development (GO:0061548) | 2.30889277 |
| 171 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.30151284 |
| 172 | macrophage activation involved in immune response (GO:0002281) | 2.29784031 |
| 173 | mesenchymal cell differentiation (GO:0048762) | 2.29161863 |
| 174 | positive regulation of defense response to virus by host (GO:0002230) | 2.29097615 |
| 175 | T cell lineage commitment (GO:0002360) | 2.27162210 |
| 176 | response to interferon-alpha (GO:0035455) | 2.26677225 |
| 177 | positive regulation of interleukin-12 production (GO:0032735) | 2.26068295 |
| 178 | negative regulation of T cell mediated immunity (GO:0002710) | 2.24466809 |
| 179 | regulation of mast cell activation (GO:0033003) | 2.24066903 |
| 180 | positive regulation of interleukin-1 production (GO:0032732) | 2.21439034 |
| 181 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.21081375 |
| 182 | positive regulation of interleukin-10 production (GO:0032733) | 2.21013535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYB_26560356_Chip-Seq_TH2_Human | 3.50744263 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.43067521 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25039960 |
| 4 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 3.10608910 |
| 5 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.84764178 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.78102958 |
| 7 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.74275288 |
| 8 | MYB_26560356_Chip-Seq_TH1_Human | 2.71886583 |
| 9 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.67165557 |
| 10 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.60614268 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.58349841 |
| 12 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.55338682 |
| 13 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.43806963 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43332978 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38480222 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.37508260 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.32496533 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.23448531 |
| 19 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.23209692 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.22293193 |
| 21 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 2.21568936 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.18779041 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.14352785 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.12896947 |
| 25 | * GATA3_26560356_Chip-Seq_TH2_Human | 2.12520080 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06708066 |
| 27 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 2.04980680 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04780529 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01173846 |
| 30 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 2.00297689 |
| 31 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 2.00088491 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99363920 |
| 33 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.99279385 |
| 34 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.99212560 |
| 35 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.98798428 |
| 36 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.98671044 |
| 37 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.95869465 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93451305 |
| 39 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.89006076 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.88520360 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.88211709 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.86274746 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.85670599 |
| 44 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.82153915 |
| 45 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.81410362 |
| 46 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.81235364 |
| 47 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.77521828 |
| 48 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.74809423 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.73794566 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73499042 |
| 51 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.70738689 |
| 52 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.70151998 |
| 53 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.70055383 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68052825 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65734501 |
| 56 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.63863396 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63723351 |
| 58 | * MAF_26560356_Chip-Seq_TH2_Human | 1.60469331 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.58649060 |
| 60 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.58403623 |
| 61 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.54974470 |
| 62 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.54247390 |
| 63 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.53993577 |
| 64 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.53619219 |
| 65 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.53591687 |
| 66 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.53361586 |
| 67 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52823764 |
| 68 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.52061631 |
| 69 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.52021014 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.51510567 |
| 71 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.49721190 |
| 72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47628427 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47199287 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47194143 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46568337 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45771881 |
| 77 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.44493831 |
| 78 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44267869 |
| 79 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41874611 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41551847 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41168573 |
| 82 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40039988 |
| 83 | EWS_26573619_Chip-Seq_HEK293_Human | 1.39908996 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37867147 |
| 85 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36686689 |
| 86 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35334162 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35246180 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34543542 |
| 89 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34381224 |
| 90 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34023222 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33166607 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31744031 |
| 93 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31619939 |
| 94 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.30432320 |
| 95 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29875798 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.28881355 |
| 97 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.27089048 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25471169 |
| 99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23459959 |
| 100 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23110399 |
| 101 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22123702 |
| 102 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22123702 |
| 103 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21855532 |
| 104 | KDM2B_26808549_Chip-Seq_REH_Human | 1.21682828 |
| 105 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19621786 |
| 106 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19544305 |
| 107 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19360608 |
| 108 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18845716 |
| 109 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.17740799 |
| 110 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.16224025 |
| 111 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15753740 |
| 112 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14908326 |
| 113 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.14213353 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13071416 |
| 115 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11136049 |
| 116 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10546927 |
| 117 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10341291 |
| 118 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07849633 |
| 119 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07773593 |
| 120 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07399963 |
| 121 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05678327 |
| 122 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05527053 |
| 123 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04740920 |
| 124 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03688777 |
| 125 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03059638 |
| 126 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01847422 |
| 127 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01439919 |
| 128 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.01388369 |
| 129 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01122253 |
| 130 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99160846 |
| 131 | GATA3_26560356_Chip-Seq_TH1_Human | 0.98738157 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98482161 |
| 133 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98439394 |
| 134 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98088490 |
| 135 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97184100 |
| 136 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96699616 |
| 137 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96437928 |
| 138 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.96134959 |
| 139 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96133767 |
| 140 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96080281 |
| 141 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96045646 |
| 142 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.95032924 |
| 143 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.93312517 |
| 144 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90454768 |
| 145 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89376427 |
| 146 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88955502 |
| 147 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88928575 |
| 148 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.87355151 |
| 149 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.86432254 |
| 150 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83642945 |
| 151 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83580235 |
| 152 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83181535 |
| 153 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82843763 |
| 154 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82000703 |
| 155 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81392497 |
| 156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81352386 |
| 157 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81082609 |
| 158 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79947107 |
| 159 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79551237 |
| 160 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76184518 |
| 161 | P300_27268052_Chip-Seq_Bcells_Human | 0.74064657 |
| 162 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70429556 |
| 163 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70414633 |
| 164 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.69616769 |
| 165 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.69351067 |
| 166 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66471648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.91017129 |
| 2 | MP0001188_hyperpigmentation | 3.59112282 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.44664249 |
| 4 | MP0005671_abnormal_response_to | 2.55054233 |
| 5 | MP0005387_immune_system_phenotype | 2.46389304 |
| 6 | MP0001790_abnormal_immune_system | 2.46389304 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.45681247 |
| 8 | MP0009785_altered_susceptibility_to | 2.43086049 |
| 9 | MP0000566_synostosis | 2.39757777 |
| 10 | MP0000015_abnormal_ear_pigmentation | 2.33712618 |
| 11 | MP0000703_abnormal_thymus_morphology | 2.27042909 |
| 12 | MP0002102_abnormal_ear_morphology | 2.25644906 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.24045543 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.19397107 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.15071299 |
| 16 | MP0002277_abnormal_respiratory_mucosa | 2.13897431 |
| 17 | MP0002419_abnormal_innate_immunity | 2.06051543 |
| 18 | MP0003787_abnormal_imprinting | 2.04948504 |
| 19 | MP0005409_darkened_coat_color | 2.03909907 |
| 20 | MP0003136_yellow_coat_color | 2.03102354 |
| 21 | * MP0001800_abnormal_humoral_immune | 2.02489402 |
| 22 | MP0005171_absent_coat_pigmentation | 2.00006475 |
| 23 | * MP0002452_abnormal_antigen_presenting | 1.97360451 |
| 24 | MP0002876_abnormal_thyroid_physiology | 1.96678131 |
| 25 | MP0003866_abnormal_defecation | 1.91224631 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.89164116 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.88636742 |
| 28 | * MP0002723_abnormal_immune_serum | 1.85191078 |
| 29 | MP0005025_abnormal_response_to | 1.84721597 |
| 30 | MP0003724_increased_susceptibility_to | 1.84027768 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.83071903 |
| 32 | MP0009764_decreased_sensitivity_to | 1.82783094 |
| 33 | MP0009697_abnormal_copulation | 1.82488016 |
| 34 | MP0004510_myositis | 1.74309546 |
| 35 | * MP0001819_abnormal_immune_cell | 1.67775835 |
| 36 | * MP0002420_abnormal_adaptive_immunity | 1.66124092 |
| 37 | MP0003303_peritoneal_inflammation | 1.64113503 |
| 38 | MP0006082_CNS_inflammation | 1.57097643 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.55059725 |
| 40 | MP0005451_abnormal_body_composition | 1.51505108 |
| 41 | MP0005670_abnormal_white_adipose | 1.51379808 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.50945793 |
| 43 | MP0003941_abnormal_skin_development | 1.50554007 |
| 44 | MP0003045_fibrosis | 1.50329594 |
| 45 | MP0000685_abnormal_immune_system | 1.48085802 |
| 46 | MP0004947_skin_inflammation | 1.48063464 |
| 47 | MP0004381_abnormal_hair_follicle | 1.46948279 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.46217018 |
| 49 | MP0003436_decreased_susceptibility_to | 1.44656398 |
| 50 | MP0008058_abnormal_DNA_repair | 1.42519473 |
| 51 | MP0008260_abnormal_autophagy | 1.42334567 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.40663617 |
| 53 | MP0002163_abnormal_gland_morphology | 1.40602662 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.39741743 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.31919501 |
| 56 | MP0000383_abnormal_hair_follicle | 1.31315317 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.30075970 |
| 58 | MP0000490_abnormal_crypts_of | 1.26973050 |
| 59 | MP0008057_abnormal_DNA_replication | 1.26101724 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 1.26012709 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.25723799 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.25204720 |
| 63 | MP0000372_irregular_coat_pigmentation | 1.24208683 |
| 64 | MP0001873_stomach_inflammation | 1.23493718 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.22038105 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.21584910 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.21146649 |
| 68 | MP0002928_abnormal_bile_duct | 1.18324434 |
| 69 | * MP0000716_abnormal_immune_system | 1.17286601 |
| 70 | MP0002095_abnormal_skin_pigmentation | 1.17015088 |
| 71 | MP0002006_tumorigenesis | 1.15599914 |
| 72 | MP0001346_abnormal_lacrimal_gland | 1.15371673 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.13762408 |
| 74 | * MP0002398_abnormal_bone_marrow | 1.12280547 |
| 75 | MP0002933_joint_inflammation | 1.11238381 |
| 76 | MP0003279_aneurysm | 1.09082338 |
| 77 | MP0002132_abnormal_respiratory_system | 1.06882138 |
| 78 | MP0005310_abnormal_salivary_gland | 1.05085220 |
| 79 | MP0002735_abnormal_chemical_nociception | 1.05067194 |
| 80 | MP0001845_abnormal_inflammatory_respons | 1.04948214 |
| 81 | MP0001853_heart_inflammation | 1.03414547 |
| 82 | MP0008877_abnormal_DNA_methylation | 1.03407461 |
| 83 | MP0002405_respiratory_system_inflammati | 1.02971291 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 0.97462607 |
| 85 | MP0004742_abnormal_vestibular_system | 0.96986500 |
| 86 | MP0008004_abnormal_stomach_pH | 0.96934613 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.96691779 |
| 88 | MP0002009_preneoplasia | 0.95132304 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.92671680 |
| 90 | MP0001186_pigmentation_phenotype | 0.92080301 |
| 91 | MP0004484_altered_response_of | 0.91683148 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.91046134 |
| 93 | MP0001851_eye_inflammation | 0.89276995 |
| 94 | MP0000681_abnormal_thyroid_gland | 0.87210586 |
| 95 | MP0002166_altered_tumor_susceptibility | 0.86677510 |
| 96 | MP0000579_abnormal_nail_morphology | 0.86668798 |
| 97 | MP0001663_abnormal_digestive_system | 0.84518898 |
| 98 | MP0005503_abnormal_tendon_morphology | 0.84055194 |
| 99 | MP0002168_other_aberrant_phenotype | 0.83207301 |
| 100 | * MP0002429_abnormal_blood_cell | 0.80481581 |
| 101 | MP0001502_abnormal_circadian_rhythm | 0.80346311 |
| 102 | MP0002638_abnormal_pupillary_reflex | 0.79821312 |
| 103 | MP0002722_abnormal_immune_system | 0.77862664 |
| 104 | MP0003183_abnormal_peptide_metabolism | 0.77671609 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.77595321 |
| 106 | MP0002075_abnormal_coat/hair_pigmentati | 0.76122914 |
| 107 | MP0005390_skeleton_phenotype | 0.75550372 |
| 108 | MP0000371_diluted_coat_color | 0.75235319 |
| 109 | MP0003868_abnormal_feces_composition | 0.75032253 |
| 110 | MP0002938_white_spotting | 0.74879196 |
| 111 | MP0008995_early_reproductive_senescence | 0.74703887 |
| 112 | MP0000858_altered_metastatic_potential | 0.74695739 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.73069217 |
| 114 | MP0001545_abnormal_hematopoietic_system | 0.70938625 |
| 115 | MP0005397_hematopoietic_system_phenotyp | 0.70938625 |
| 116 | MP0003828_pulmonary_edema | 0.70814650 |
| 117 | MP0009278_abnormal_bone_marrow | 0.69981537 |
| 118 | MP0008469_abnormal_protein_level | 0.69108951 |
| 119 | MP0003448_altered_tumor_morphology | 0.69071940 |
| 120 | MP0006054_spinal_hemorrhage | 0.65952467 |
| 121 | MP0001348_abnormal_lacrimal_gland | 0.64393842 |
| 122 | MP0000249_abnormal_blood_vessel | 0.62461508 |
| 123 | MP0008961_abnormal_basal_metabolism | 0.60056780 |
| 124 | MP0009763_increased_sensitivity_to | 0.59679157 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.59599665 |
| 126 | MP0002693_abnormal_pancreas_physiology | 0.59247759 |
| 127 | MP0004883_abnormal_blood_vessel | 0.58542942 |
| 128 | MP0008872_abnormal_physiological_respon | 0.58512007 |
| 129 | MP0003795_abnormal_bone_structure | 0.57822095 |
| 130 | MP0003646_muscle_fatigue | 0.57600350 |
| 131 | MP0000470_abnormal_stomach_morphology | 0.56046345 |
| 132 | MP0001958_emphysema | 0.52157474 |
| 133 | MP0005381_digestive/alimentary_phenotyp | 0.49953690 |
| 134 | MP0001764_abnormal_homeostasis | 0.49104233 |
| 135 | MP0002254_reproductive_system_inflammat | 0.47896329 |
| 136 | MP0003252_abnormal_bile_duct | 0.46122709 |
| 137 | MP0001919_abnormal_reproductive_system | 0.45806005 |
| 138 | MP0009115_abnormal_fat_cell | 0.44844470 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.40451846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.84622007 |
| 2 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 5.52591419 |
| 3 | Chromsome breakage (HP:0040012) | 5.04767261 |
| 4 | Abnormality of T cells (HP:0002843) | 4.66421574 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 4.11024977 |
| 6 | Prostate neoplasm (HP:0100787) | 3.90700501 |
| 7 | Recurrent bronchitis (HP:0002837) | 3.90448812 |
| 8 | Abnormality of T cell physiology (HP:0011840) | 3.74923477 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.73313513 |
| 10 | Pustule (HP:0200039) | 3.62359426 |
| 11 | Autoimmune hemolytic anemia (HP:0001890) | 3.53563883 |
| 12 | IgM deficiency (HP:0002850) | 3.51385647 |
| 13 | Lymphopenia (HP:0001888) | 3.49391783 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.47323466 |
| 15 | Gastrointestinal stroma tumor (HP:0100723) | 3.34985758 |
| 16 | Abnormality of eosinophils (HP:0001879) | 3.32919236 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.32875273 |
| 18 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.26634441 |
| 19 | Febrile seizures (HP:0002373) | 3.25737665 |
| 20 | Colitis (HP:0002583) | 3.21200119 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.20795520 |
| 22 | Combined immunodeficiency (HP:0005387) | 3.17432901 |
| 23 | Optic neuritis (HP:0100653) | 3.16656522 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.16656522 |
| 25 | Mesomelia (HP:0003027) | 3.14690695 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.13085119 |
| 27 | Granulocytopenia (HP:0001913) | 3.09090864 |
| 28 | Stomach cancer (HP:0012126) | 3.08173712 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 3.02177153 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.97092995 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.97092995 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.96992186 |
| 33 | Abnormality of B cell number (HP:0010975) | 2.93454601 |
| 34 | Leukocytosis (HP:0001974) | 2.91425572 |
| 35 | Duplicated collecting system (HP:0000081) | 2.88507362 |
| 36 | Abnormality of the prostate (HP:0008775) | 2.84857900 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.82245934 |
| 38 | Abnormality of the renal collecting system (HP:0004742) | 2.81933058 |
| 39 | Recurrent fungal infections (HP:0002841) | 2.80499750 |
| 40 | Recurrent pneumonia (HP:0006532) | 2.73832108 |
| 41 | IgA deficiency (HP:0002720) | 2.69522165 |
| 42 | Hypoplasia of the thymus (HP:0000778) | 2.69284229 |
| 43 | Papilloma (HP:0012740) | 2.67117844 |
| 44 | Verrucae (HP:0200043) | 2.67117844 |
| 45 | Clubbing of toes (HP:0100760) | 2.64616835 |
| 46 | Chronic diarrhea (HP:0002028) | 2.64513626 |
| 47 | Myositis (HP:0100614) | 2.61622648 |
| 48 | Renal cortical cysts (HP:0000803) | 2.58244801 |
| 49 | Hemoptysis (HP:0002105) | 2.58058326 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.57882245 |
| 51 | Obstructive lung disease (HP:0006536) | 2.57882245 |
| 52 | Hypoproteinemia (HP:0003075) | 2.57847742 |
| 53 | Alveolar cell carcinoma (HP:0006519) | 2.57081978 |
| 54 | Upper limb muscle weakness (HP:0003484) | 2.52310385 |
| 55 | Lymphoma (HP:0002665) | 2.51896858 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.50536064 |
| 57 | Chronic hepatic failure (HP:0100626) | 2.48943208 |
| 58 | Chest pain (HP:0100749) | 2.47487709 |
| 59 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.45772569 |
| 60 | Meningitis (HP:0001287) | 2.40600097 |
| 61 | Abnormality of the preputium (HP:0100587) | 2.40579175 |
| 62 | Agammaglobulinemia (HP:0004432) | 2.38633178 |
| 63 | Abnormality of DNA repair (HP:0003254) | 2.38517847 |
| 64 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.36521621 |
| 65 | Orchitis (HP:0100796) | 2.36434321 |
| 66 | Congenital sensorineural hearing impairment (HP:0008527) | 2.35429341 |
| 67 | Chronic otitis media (HP:0000389) | 2.34913790 |
| 68 | Abnormality of incisor morphology (HP:0011063) | 2.32815793 |
| 69 | Viral hepatitis (HP:0006562) | 2.32523878 |
| 70 | White forelock (HP:0002211) | 2.31975435 |
| 71 | Gingivitis (HP:0000230) | 2.30832321 |
| 72 | Recurrent lower respiratory tract infections (HP:0002783) | 2.28870273 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28826321 |
| 74 | Lip pit (HP:0100267) | 2.28746243 |
| 75 | B lymphocytopenia (HP:0010976) | 2.28670000 |
| 76 | Vasculitis (HP:0002633) | 2.27564603 |
| 77 | Cellulitis (HP:0100658) | 2.27192880 |
| 78 | Patchy hypopigmentation of hair (HP:0011365) | 2.26984460 |
| 79 | Tubulointerstitial nephritis (HP:0001970) | 2.25421162 |
| 80 | Bronchitis (HP:0012387) | 2.25047238 |
| 81 | Septo-optic dysplasia (HP:0100842) | 2.24873818 |
| 82 | Recurrent skin infections (HP:0001581) | 2.23750340 |
| 83 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.23177116 |
| 84 | Thyroiditis (HP:0100646) | 2.22743150 |
| 85 | Basal cell carcinoma (HP:0002671) | 2.20373067 |
| 86 | Abnormality of chromosome stability (HP:0003220) | 2.19703827 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 2.19127348 |
| 88 | Panhypogammaglobulinemia (HP:0003139) | 2.16629783 |
| 89 | Aplasia cutis congenita (HP:0001057) | 2.15500056 |
| 90 | Increased IgE level (HP:0003212) | 2.14906752 |
| 91 | Emphysema (HP:0002097) | 2.14004135 |
| 92 | Meckel diverticulum (HP:0002245) | 2.13677689 |
| 93 | Abnormality of the pleura (HP:0002103) | 2.13538843 |
| 94 | Ectopic kidney (HP:0000086) | 2.10506081 |
| 95 | Fair hair (HP:0002286) | 2.10418355 |
| 96 | Hypothermia (HP:0002045) | 2.08604523 |
| 97 | Increased IgM level (HP:0003496) | 2.08017038 |
| 98 | Median cleft lip (HP:0000161) | 2.07463213 |
| 99 | Congenital stationary night blindness (HP:0007642) | 2.07128786 |
| 100 | Papilledema (HP:0001085) | 2.06963319 |
| 101 | Basal ganglia calcification (HP:0002135) | 2.06804692 |
| 102 | Osteomyelitis (HP:0002754) | 2.06692462 |
| 103 | Abnormality of the nasal septum (HP:0000419) | 2.06620552 |
| 104 | Abnormality of the ileum (HP:0001549) | 2.03890638 |
| 105 | Prolonged bleeding time (HP:0003010) | 2.03772455 |
| 106 | Decreased central vision (HP:0007663) | 2.02416530 |
| 107 | Hypochromic anemia (HP:0001931) | 1.99286705 |
| 108 | Eosinophilia (HP:0001880) | 1.98006824 |
| 109 | Recurrent viral infections (HP:0004429) | 1.94177708 |
| 110 | Restrictive lung disease (HP:0002091) | 1.94095146 |
| 111 | Distal lower limb muscle weakness (HP:0009053) | 1.93294391 |
| 112 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.92473733 |
| 113 | Absent frontal sinuses (HP:0002688) | 1.92337704 |
| 114 | Autoimmune thrombocytopenia (HP:0001973) | 1.92078130 |
| 115 | Premature loss of primary teeth (HP:0006323) | 1.92057687 |
| 116 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.91758679 |
| 117 | Hypoplasia of the fovea (HP:0007750) | 1.91758679 |
| 118 | Pulmonary embolism (HP:0002204) | 1.89933801 |
| 119 | Recurrent sinusitis (HP:0011108) | 1.89771916 |
| 120 | Tetany (HP:0001281) | 1.89186216 |
| 121 | Encephalitis (HP:0002383) | 1.88461678 |
| 122 | Sepsis (HP:0100806) | 1.88016408 |
| 123 | Arterial thrombosis (HP:0004420) | 1.87951528 |
| 124 | Spondylolisthesis (HP:0003302) | 1.85780664 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.85722359 |
| 126 | Hypergonadotropic hypogonadism (HP:0000815) | 1.85391809 |
| 127 | Abnormality of the renal cortex (HP:0011035) | 1.83764483 |
| 128 | Abnormality of the peritoneum (HP:0002585) | 1.83210507 |
| 129 | Conical tooth (HP:0000698) | 1.83024934 |
| 130 | Protruding tongue (HP:0010808) | 1.82959274 |
| 131 | Generalized hypopigmentation of hair (HP:0011358) | 1.82448363 |
| 132 | Attenuation of retinal blood vessels (HP:0007843) | 1.82130044 |
| 133 | Hematochezia (HP:0002573) | 1.81923068 |
| 134 | Abnormal ciliary motility (HP:0012262) | 1.81126547 |
| 135 | Pulmonary infiltrates (HP:0002113) | 1.81005739 |
| 136 | Congenital hepatic fibrosis (HP:0002612) | 1.80639580 |
| 137 | Syringomyelia (HP:0003396) | 1.79290339 |
| 138 | Spinal cord lesions (HP:0100561) | 1.79290339 |
| 139 | Keratoconjunctivitis sicca (HP:0001097) | 1.79277050 |
| 140 | Stomatitis (HP:0010280) | 1.79093250 |
| 141 | Cheilitis (HP:0100825) | 1.77386258 |
| 142 | Epistaxis (HP:0000421) | 1.77191891 |
| 143 | Abnormality of T cell number (HP:0011839) | 1.75228882 |
| 144 | Leukopenia (HP:0001882) | 1.75157543 |
| 145 | Ectropion (HP:0000656) | 1.74431303 |
| 146 | Abnormality of the fingertips (HP:0001211) | 1.74303287 |
| 147 | Neonatal hypoglycemia (HP:0001998) | 1.74263709 |
| 148 | Chronic sinusitis (HP:0011109) | 1.73361958 |
| 149 | Abnormality of male internal genitalia (HP:0000022) | 1.72924752 |
| 150 | Abnormal hair whorl (HP:0010721) | 1.72746809 |
| 151 | Abnormality of macrophages (HP:0004311) | 1.70007380 |
| 152 | Keratoconjunctivitis (HP:0001096) | 1.69842706 |
| 153 | Periodontitis (HP:0000704) | 1.69775106 |
| 154 | Postaxial foot polydactyly (HP:0001830) | 1.69685906 |
| 155 | True hermaphroditism (HP:0010459) | 1.69138295 |
| 156 | Abnormality of the carotid arteries (HP:0005344) | 1.68900097 |
| 157 | IgG deficiency (HP:0004315) | 1.68762691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.45784297 |
| 2 | IRAK3 | 3.23994060 |
| 3 | CASK | 3.18086082 |
| 4 | TXK | 3.17463471 |
| 5 | IRAK4 | 2.70301914 |
| 6 | EIF2AK2 | 2.60912709 |
| 7 | ZAK | 2.49957115 |
| 8 | TNIK | 2.43424548 |
| 9 | INSRR | 2.08417168 |
| 10 | SIK3 | 2.06091505 |
| 11 | GRK6 | 2.02952050 |
| 12 | ZAP70 | 2.00570118 |
| 13 | TEC | 1.78234551 |
| 14 | IKBKE | 1.72004926 |
| 15 | YES1 | 1.69689487 |
| 16 | RIPK4 | 1.66739895 |
| 17 | IKBKB | 1.62434670 |
| 18 | ADRBK2 | 1.59378355 |
| 19 | JAK1 | 1.56884727 |
| 20 | GRK1 | 1.52422381 |
| 21 | JAK3 | 1.50551359 |
| 22 | NUAK1 | 1.49526676 |
| 23 | MKNK2 | 1.48345653 |
| 24 | PRPF4B | 1.47490267 |
| 25 | TGFBR2 | 1.47246188 |
| 26 | BMPR2 | 1.44084001 |
| 27 | STK16 | 1.43920751 |
| 28 | FRK | 1.35365291 |
| 29 | IRAK1 | 1.35010515 |
| 30 | NLK | 1.31836606 |
| 31 | BLK | 1.31637387 |
| 32 | GRK7 | 1.27453435 |
| 33 | MAP3K10 | 1.23564063 |
| 34 | MUSK | 1.22832456 |
| 35 | BRD4 | 1.21642648 |
| 36 | CDK3 | 1.20445764 |
| 37 | TBK1 | 1.18556286 |
| 38 | MAP4K1 | 1.17438419 |
| 39 | KIT | 1.17242746 |
| 40 | MAP2K7 | 1.12477266 |
| 41 | CLK1 | 1.11729471 |
| 42 | EPHA3 | 1.10963826 |
| 43 | PIK3CG | 1.08536723 |
| 44 | CHUK | 1.04741448 |
| 45 | SGK2 | 1.04648260 |
| 46 | ERN1 | 1.04467937 |
| 47 | TLK1 | 1.04427869 |
| 48 | PASK | 1.02221261 |
| 49 | ACVR1B | 1.00882344 |
| 50 | TNK2 | 0.99782513 |
| 51 | LYN | 0.95663250 |
| 52 | FGFR4 | 0.94900209 |
| 53 | MELK | 0.93459348 |
| 54 | SYK | 0.93362653 |
| 55 | BTK | 0.90364916 |
| 56 | NEK6 | 0.89184947 |
| 57 | STK38L | 0.88979201 |
| 58 | BMPR1B | 0.88727231 |
| 59 | TRPM7 | 0.87674094 |
| 60 | MAP3K13 | 0.86726239 |
| 61 | TYK2 | 0.85633123 |
| 62 | CSF1R | 0.84878455 |
| 63 | TAOK3 | 0.84083447 |
| 64 | MAPK11 | 0.83809577 |
| 65 | MAP3K7 | 0.83089538 |
| 66 | MAP4K2 | 0.79550430 |
| 67 | CDK4 | 0.78441804 |
| 68 | KDR | 0.76862888 |
| 69 | CAMK1D | 0.76432039 |
| 70 | MKNK1 | 0.75151769 |
| 71 | HCK | 0.74949071 |
| 72 | CDC42BPA | 0.74850123 |
| 73 | CAMKK2 | 0.74359695 |
| 74 | STK24 | 0.73434031 |
| 75 | LCK | 0.73166351 |
| 76 | CDK8 | 0.72987097 |
| 77 | ITK | 0.72936411 |
| 78 | ERBB3 | 0.71596793 |
| 79 | MAPK7 | 0.70447769 |
| 80 | STK4 | 0.69894137 |
| 81 | OBSCN | 0.69403869 |
| 82 | MAPK13 | 0.69100951 |
| 83 | MAP2K2 | 0.68545016 |
| 84 | AKT3 | 0.66314356 |
| 85 | PIM1 | 0.65675063 |
| 86 | TAOK2 | 0.65490940 |
| 87 | JAK2 | 0.65251541 |
| 88 | IRAK2 | 0.65207771 |
| 89 | RPS6KA4 | 0.65202485 |
| 90 | EIF2AK3 | 0.65043969 |
| 91 | PLK4 | 0.65024481 |
| 92 | STK3 | 0.64067362 |
| 93 | SRPK1 | 0.64037209 |
| 94 | ATR | 0.62971695 |
| 95 | HIPK2 | 0.62670628 |
| 96 | PBK | 0.60989810 |
| 97 | STK10 | 0.60683651 |
| 98 | PIK3CA | 0.58995624 |
| 99 | PDK1 | 0.58747763 |
| 100 | CSK | 0.58242214 |
| 101 | FGFR3 | 0.57387999 |
| 102 | MAPKAPK3 | 0.56504312 |
| 103 | PRKCE | 0.56134592 |
| 104 | MAP2K3 | 0.55241343 |
| 105 | SIK2 | 0.55075681 |
| 106 | NME2 | 0.54952474 |
| 107 | CAMKK1 | 0.54183017 |
| 108 | MAP2K6 | 0.53337365 |
| 109 | PRKCQ | 0.52238276 |
| 110 | OXSR1 | 0.50666188 |
| 111 | PKN1 | 0.50643194 |
| 112 | CDK19 | 0.50384061 |
| 113 | SGK3 | 0.48695060 |
| 114 | SGK1 | 0.47047291 |
| 115 | PRKCH | 0.46983394 |
| 116 | PRKAA2 | 0.46577123 |
| 117 | CDK9 | 0.46454695 |
| 118 | VRK1 | 0.45615545 |
| 119 | FYN | 0.44737947 |
| 120 | NEK9 | 0.44632300 |
| 121 | CDK12 | 0.43753914 |
| 122 | PRKD2 | 0.43150736 |
| 123 | ABL1 | 0.42788227 |
| 124 | IGF1R | 0.42623664 |
| 125 | WNK4 | 0.41656748 |
| 126 | MARK3 | 0.41288177 |
| 127 | NTRK3 | 0.41073208 |
| 128 | TIE1 | 0.41056781 |
| 129 | MATK | 0.39121828 |
| 130 | WNK1 | 0.39035864 |
| 131 | PRKCD | 0.38491788 |
| 132 | FES | 0.38324589 |
| 133 | STK39 | 0.38232962 |
| 134 | PLK2 | 0.37638714 |
| 135 | FGR | 0.37016531 |
| 136 | MAP3K5 | 0.36645282 |
| 137 | INSR | 0.35120706 |
| 138 | ADRBK1 | 0.34651773 |
| 139 | MAPK3 | 0.34081628 |
| 140 | MAPK12 | 0.34030568 |
| 141 | EGFR | 0.33862390 |
| 142 | MAPKAPK2 | 0.33148605 |
| 143 | EPHB1 | 0.32328190 |
| 144 | RPS6KA6 | 0.31417247 |
| 145 | FLT3 | 0.30996904 |
| 146 | CDK6 | 0.30760978 |
| 147 | PTK2B | 0.29934968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.47699858 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.44977693 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.43831870 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.39418901 |
| 5 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35847575 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35560990 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.17496981 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.14106153 |
| 9 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.06129410 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.99362121 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.97583867 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.93297821 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.90382804 |
| 14 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.87740067 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.83412535 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81479344 |
| 17 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.73037530 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61611896 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.56877460 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.56648785 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55013426 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.52482077 |
| 23 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.39450600 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36187059 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.36117279 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.35123169 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34279766 |
| 28 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.33962902 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.30570083 |
| 30 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.28378848 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.23517958 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20916849 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14931762 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14737641 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13314577 |
| 36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13165202 |
| 37 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11646377 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.10770380 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09728967 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.08864379 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08156649 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06307379 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.02976381 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.99778730 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95115728 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94835516 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.91429513 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.90624075 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90587969 |
| 50 | Nicotine addiction_Homo sapiens_hsa05033 | 0.89747066 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88918913 |
| 52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87712200 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85573951 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.85568561 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 0.85451569 |
| 56 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84655400 |
| 57 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84085309 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.81242637 |
| 59 | Morphine addiction_Homo sapiens_hsa05032 | 0.80868825 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80704899 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.78867070 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75785904 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.73290021 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73003870 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.72864783 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72034642 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70833142 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69935407 |
| 69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68632070 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65985334 |
| 71 | Taste transduction_Homo sapiens_hsa04742 | 0.65058365 |
| 72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63737618 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62736109 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61066640 |
| 75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58796260 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56023354 |
| 77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55688342 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.55531250 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.55247812 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53875294 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53392953 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51651746 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51192700 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49995942 |
| 85 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49651477 |
| 86 | Base excision repair_Homo sapiens_hsa03410 | 0.48563830 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46361650 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45790912 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44388134 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43824632 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43076242 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42649325 |
| 93 | RNA degradation_Homo sapiens_hsa03018 | 0.42423105 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41550722 |
| 95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41304376 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41134768 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.40801541 |
| 98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40644945 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40128196 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.38974380 |
| 101 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38758258 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38693488 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38601130 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37999552 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.36273440 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34860002 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34413736 |
| 108 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32326381 |
| 109 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32134367 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.31520220 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31410030 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31150126 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30808182 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30574694 |
| 115 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.29870781 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29379344 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29078927 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28581717 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.28523292 |
| 120 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28500219 |
| 121 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.28254587 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27994319 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27994082 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27647420 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26075903 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25896540 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23582896 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21591799 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.21261264 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18664204 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.17087395 |

